0001231919-21-000018.txt : 20210218 0001231919-21-000018.hdr.sgml : 20210218 20210218111818 ACCESSION NUMBER: 0001231919-21-000018 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210218 DATE AS OF CHANGE: 20210218 EFFECTIVENESS DATE: 20210218 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Silence Therapeutics plc CENTRAL INDEX KEY: 0001479615 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-389800 FILM NUMBER: 21648296 BUSINESS ADDRESS: STREET 1: 72 HAMMERSMITH ROAD CITY: LONDON STATE: X0 ZIP: W14 8TH BUSINESS PHONE: 44-0-20-3457 6900 MAIL ADDRESS: STREET 1: 72 HAMMERSMITH ROAD CITY: LONDON STATE: X0 ZIP: W14 8TH D 1 primary_doc.xml X0708 D LIVE 0001479615 Silence Therapeutics plc 72 HAMMERSMITH ROAD LONDON X0 UNITED KINGDOM W14 8TH 44-0-20-3457 6900 UNITED KINGDOM None None Corporation true Mark Rothera c/o Silence Therapeutics plc 72 Hammersmith Road London X0 UNITED KINGDOM W14 8TH Executive Officer Director Craig Tooman c/o Silence Therapeutics plc 72 Hammersmith Road London X0 UNITED KINGDOM W14 8TH Executive Officer Giles Campion c/o Silence Therapeutics plc 72 Hammersmith Road London X0 UNITED KINGDOM W14 8TH Executive Officer Dave Lemus c/o Silence Therapeutics plc 72 Hammersmith Road London X0 UNITED KINGDOM W14 8TH Director Iain Ross c/o Silence Therapeutics plc 72 Hammersmith Road London X0 UNITED KINGDOM W14 8TH Director James Ede-Golightly c/o Silence Therapeutics plc 72 Hammersmith Road London X0 UNITED KINGDOM W14 8TH Director Alistair Gray c/o Silence Therapeutics plc 72 Hammersmith Road London X0 UNITED KINGDOM W14 8TH Director Barbara Ruskin c/o Silence Therapeutics plc 72 Hammersmith Road London X0 UNITED KINGDOM W14 8TH Executive Officer Romano Steven c/o Silence Therapeutics plc 72 Hammersmith Road London X0 UNITED KINGDOM W14 8TH Director Michael H. Davidson c/o Silence Therapeutics plc 72 Hammersmith Road London X0 UNITED KINGDOM W14 8TH Director Biotechnology Decline to Disclose 06b false 2021-02-04 false true false 0 William Blair & Company, L.L.C. 1252 None None The William Blair Building 150 North Riverside Plaza Chicago IL ILLINOIS 60606 CA CALIFORNIA CT CONNECTICUT FL FLORIDA MA MASSACHUSETTS NY NEW YORK false 45499905 45499905 0 false 12 2730000 0 0 false Silence Therapeutics plc /s/ Mark Rothera Mark Rothera President & CEO 2021-02-18